How can pharma marketers 'friend' social media?

Share this article:
Communicating with patients through social media presents significant challenges, but also tremendous opportunities, for pharma marketers. 

First, let's acknowledge the challenges. How do we ensure compliance with regulations that have struggled to keep pace with rapidly evolving online communications channels like YouTube, Facebook and Twitter? How do we calculate the ROI for social media? How do we navigate a communications environment that seems to turn some of our core assumptions about pharma marketing upside-down?

When communicating with patient audiences through social media, the first thing we need to ask ourselves is not what message we want to see penetrate a given blog or forum, but how we can contribute to an ongoing two-way dialogue with the community and meet people where they are seeking health info.

In February, Sanofi-Aventis began a new social media campaign with the launch of a YouTube diabetes channel ( Market research has revealed that many people with type 2 diabetes have reservations about insulin due to a series of deeply seeded myths and misperceptions. Research also indicated that many people with diabetes were spending time on YouTube, making a GoInsulin channel a new and exciting way to communicate with them. Pharma marketers must think about changing their approach from talking to the customer, to talking with the customer in their communities.

The channel is part of the broader GoInsulin campaign, which is designed to challenge the myths that create barriers to considering insulin use using real patients who have walked in those same shoes. The GoInsulin YouTube Channel features real-life inspiring video stories of people with type 2 diabetes who use insulin as part of their overall diabetes treatment plan. 

The GoInsulin YouTube channel provides an example of how social media can be used to confront a marketing challenge—in this case, the myths and misperceptions associated with insulin. The emergence of social media does not represent a paradigm shift in pharmaceutical marketing, at least not yet… but companies that take a proactive stance and cultivate relationships with online communities will be poised for future success as the communications landscape continues to evolve.  

This could be the beginning of a wonderful friendship! 

Lynn Crowe is senior product manager, metabolism marketing, Sanofi-Aventis US
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.